Hundreds of leaders in Access, Reimbursement, Managed Markets and Commercial Operations have benefited from CBI’s Reimbursement and Access Congress. Now in its 5th year, this highly-acclaimed event addresses the challenges bio/pharma manufacturers face around regulatory hurdles, drug price scrutiny and demonstrating product value. Benefit from invaluable learning and benchmarking, covering the most impactful pricing and reimbursement trends and access strategies!
CLE & CPE Credits Available! Pending Approval
Interactive Panels, Compelling Sessions and Expert Insights on the Most Pressing Issues:
Benefit From Two Tracks of Tailored Content:
I: Payer Strategies and Reimbursement
II: Access and Affordability